European patent office restores breast cancer gene patent
November 20, 2008The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.
Content from AFP expires 1 month after original publication date. For more information about AFP, please visit www.afp.com .
Similar stories from PHYSorg:
Microsoft to appeal Word patent ruling
Aug 12, 2009 |
1.7 / 5 (6) |
5
TiVo Inc. sues AT&T, Verizon over DVR patents
Aug 27, 2009 |
not rated yet |
0
Microsoft ordered to pay $200 mln in patent case
May 20, 2009 |
5 / 5 (2) |
3
Canadian firm predicts victory in Microsoft patent case
Sep 04, 2009 |
4 / 5 (4) |
1
DNA Fingerprinting Identifies Bean in Patent Dispute
May 27, 2008 |
5 / 5 (2) |
0



I am hopeful that the current progress towards rapid whole-genome sequencing will make all of these patents obsolete: nobody is going to pay for 24,000 different licences to sequence a genome, so these guys will be stuck with their useless patents.